Geographic Variation Seen in Declines in Cervical Cancer Incidence

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 24, 2026.

via HealthDay

TUESDAY, Feb. 24, 2026 -- Declines in cervical cancer incidence among young U.S. women during the human papillomavirus (HPV) vaccination era vary by geographic region, according to a study published online Feb. 23 in the Journal of the National Cancer Institute.

Chenxi Jiang, M.P.H., from the American Cancer Society in Atlanta, and colleagues used data from the U.S. Cancer Statistics Database to compare differences in cervical cancer incidence rates for women aged 20 to 31 years between the prevaccination (2000 to 2005) and vaccination eras (2016 to 2022).

The researchers found that nationwide, cervical cancer incidence rates declined from 5.1 to 3.7 per 100,000 during the vaccination era (rate ratio [RR], 0.73). There were declines >50 percent in Washington, D.C. (RR, 0.48), Rhode Island (RR, 0.48), Michigan (RR, 0.48), and Hawaii (RR, 0.49). Twenty-eight additional states had statistically significant reductions of 15 to 50 percent. Slower decreases of <15 percent were seen in 10 states. Vermont (RR, 1.11), West Virginia (RR, 1.09), Idaho (RR, 0.97), Arkansas (RR, 0.96), and Alabama (RR, 0.96) lacked progress. Higher vaccination rates were correlated with faster declines (rho = −0.42). For every 10 percent increase in vaccination rates, there was an 11.5 percent reduction in RRs when adjusted for screening rates.

"To ensure that all states benefit equally from a proven preventive measure, strengthening political commitment will be crucial, especially in states with slower progress in reducing disease burden and low vaccination rates," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-25 01:56

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords